Reproductive-endocrine point-of-care testing: Current status and limitations

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 7, 2010, Pages 935-942

  Cervinski, Mark A ^a   Gronowski, Ann M ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

diagnostic efficiency; human chorionic gonadotropin; luteinizing hormone; point of care

Indexed keywords

LUTEINIZING HORMONE;

DIAGNOSTIC ACCURACY; FERTILITY; HUMAN; OVULATION; POINT OF CARE TESTING; PREGNANCY TEST; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS;

CHORIONIC GONADOTROPIN; DIAGNOSTIC ERRORS; FEMALE; HUMANS; LUTEINIZING HORMONE; POINT-OF-CARE SYSTEMS; PREGNANCY; PREGNANCY TESTS;

EID: 77954234677     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.183     Document Type: Review

References (35)

1. WHO. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 b, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction. Am J Obstet Gynecol 1980;138:383-390
2. Seibel MM. Luteinizing hormone and ovulation timing. J Reprod Med 1986;31(8 Suppl):754-759
3. When the test really counts. Consumer Reports 2003 February: 45-50.
4. Miller PB, Soules MR. The usefulness of a urinary LH kit for ovulation prediction during menstrual cycles of normal women. Obstet Gynecol 1996;87:13-17
5. Cahill DJ, Wardle PG, Harlow CR, Hull MG. Onset of the preovulatory luteinizing hormone surge: diurnal timing and critical follicular prerequisites. Fertil Steril 1998;70:56-59
6. Edwards RG. Test-tube babies, 1981. Nature 1981;293:253-256
7. Guermandi E, Vegetti W, Bianchi MM, Uglietti A, Ragni G, Crosignani P. Reliability of ovulation tests in infertile women. Obstet Gynecol 2001;97:92-96
8. Lloyd R, Coulam CB. The accuracy of urinary luteinizing hormone testing in predicting ovulation. Am J Obstet Gynecol 1989;160:1370-2; discussion 1373-1375
9. Elkind-Hirsch K, Goldzieher JW, Gibbons WE, Besch PK. Evaluation of the OvuSTICK urinary luteinizing hormone kit in normal and stimulated menstrual cycles. Obstet Gynecol 1986;67:450-453
10. Gudgeon K, Leader L, Howard B. Evaluation of the accuracy of the home ovulation detection kit, clearplan, at predicting ovulation. Med J Aust 1990;152:344, 346, 349.
11. Gronowski AM, Grenache DG, Markenson G, Weiner R, Demers LM, St. Louis P. Reproductive Testing. In: Nichols JH, editor. The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: evidence-based practice for point-of-care testing.Washington, DC: AACC Press, 2007:135-148
12. Robinson JN, Lockwood GM, Dalton JD, Franklin PA, Farr MM, Barlow DH. A randomized prospective study to assess the effect of the use of home urinary luteinizing hormone detection on the efficiency of donor insemination. Hum Reprod 1992;7:63-65
13. Federman CA, Dumesic DA, Boone WR, Shapiro SS. Relative efficiency of therapeutic donor insemination using a luteinizing hormone monitor. Fertil Steril 1990;54:489-492
14. Barratt CL, Cooke S, Chauhan M, Cooke ID. A prospective randomized controlled trial comparing urinary luteinizing hormone dipsticks and basal body temperature charts with time donor insemination. Fertil Steril 1989;52:394-397
15. Kossoy LR, Hill GA, Parker RA, Rogers BJ, Dalglish CS, Herbert GM 3rd, et al. Luteinizing hormone and ovulation timing in a therapeutic donor insemination program using frozen semen. Am J Obstet Gynecol 1989;160:1169-1172
16. Odem RR, Durso NM, Long CA, Pineda JA, Strickler RC, Gast MJ. Therapeutic donor insemination: a prospective randomized study of scheduling methods. Fertil Steril 1991;55:976-982
17. Horne G, Jamaludin A, Critchlow JD, Falconer DA, Newman MC, Oghoetuoma J, et al. A 3 year retrospective review of intrauterine insemination, using cryopreserved donor spermatozoa and cycle monitoring by urinary or serum luteinizing hormone measurements. Hum Reprod 1998;13:3045-3048
18. Anderson RA, Eccles SM, Irvine DS. Home ovulation testing in a donor insemination service. Hum Reprod 1996;11:1674-1677
19. Robinson JE, Wakelin M, Ellis JE. Increased pregnancy rate with use of the Clearblue Easy Fertility Monitor. Fertil Steril 2007;87:329-334
20. Tanabe K, Susumu N, Hand K, Nishii K, Ishikawa I, Nozawa S. Prediction of the potentially fertile period by urinary hormone measurements using a new home-use monitor: comparison with laboratory hormone analyses. Hum Reprod 2001;16: 1619-1624
21. Behre HM, Kuhlage J, Gassner C, Sonntag B, Schem C, Schneider HP, et al. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod 2000;15:2478-2482
22. Johnson SR, Miro F, Barrett S, Ellis JE. Levels of urinary human chorionic gonadotrophin (hCG) following conception and variability of menstrual cycle length in a cohort of women attempting to conceive. Curr Med Res Opin 2009;25:741-748
23. Butler SA, Khanlian SA, Cole LA. Detection of early pregnancy forms of human chorionic gonadotropin by home pregnancy test devices. Clin Chem 2001;47:2131-2136
24. O'Connor JF, Ellish N, Kakuma T, Schlatterer J, Kovalevskaya G. Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss. Prenat Diagn 1998;18:1232-1240
25. Cervinski MA, Lockwood CM, Ferguson AM, Odem RR, Stenman UH, Alfthan H, et al. Qualitative point-of-care and overthe-counter urine hCG devices differentially detect the hCG variants of early pregnancy. Clin Chim Acta 2009;406:81-85
26. Cole LA. Human chorionic gonadotropin. In: Gronowski AM, editor. Handbook of clinical laboratory testing during pregnancy. Totowa: Humana Press, 2004:15-34.
27. Sigel CS, Grenache DG. Detection of unexpected isoforms of human chorionic gonadotropin by qualitative tests. Clin Chem 2007;53:989-990
28. Wilcox AJ, Baird DD, Dunson D, McChesney R,Weinberg CR. Natural limits of pregnancy testing in relation to the expected menstrual period. J Am Med Assoc 2001;286:1759-1761
29. Lee-Lewandrowski E, Corboy D, Lewandrowski K, Sinclair J, McDermot S, Benzer TI. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay. Arch Pathol Lab Med 2003;127:456-460
30. Plerhoples W, Zwemer FL Jr, Bazarian J. Point of care pregnancy testing provides staff satisfaction but does not change ED length of stay. Am J Emerg Med 2004;22:460-464
31. Stickle DF, Gronowski AM, Olsen GA, Fellows PA, Avery MB, Studts DJ, et al. Decreased signal intensity of Sure-Vue serum/urine qualitative hCG test at high whCGx. Clin Chem 2000;46: A3.
32. Madersbacher S, Berger P. Antibodies and immunoassays. Methods 2000;21:41-50.
33. Gronowski AM, Powers M, Stenman UH, Ashby L, Scott MG. False-negative results from point-of-care qualitative human chorionic gonadotropin (hCG) devices caused by excess h-CGbeta core fragment vary with device lot number. Clin Chem 2009;55:1885-1886.
34. Gronowski AM, Fantz CR, Parvin CA, Sokoll LJ, Wiley CL, Wener MH, et al. Use of serum FSH to identify perimenopausal women with pituitary hCG. Clin Chem 2008;54:652-656
35. Snyder JA, Haymond S, Parvin CA, Gronowski AM, Grenache DG. Diagnostic considerations in the measurement of human chorionic gonadotropin in aging women. Clin Chem 2005;51: 1830-1835